Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ChemoCentryx Inc (NASDAQ:CCXI)

6.50
Delayed Data
As of Aug 28
 -0.39 / -5.66%
Today’s Change
4.06
Today|||52-Week Range
9.46
-4.83%
Year-to-Date
No recent news for ChemoCentryx Inc.

Today’s Trading

Previous close6.89
Today’s open6.93
Day’s range6.36 - 6.93
Volume99,757
Average volume (3 months)139,146
Market cap$286.5M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-13.68%
Earnings growth (this year)-3.70%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.60

Competitors

 Today’s
change
Today’s
% change
PTXPernix Therapeutics ...+0.10+2.17%
POZNPOZEN Inc+0.02+0.23%
SNTASynta Pharmaceutical...+0.08+4.04%
ANTHAnthera Pharmaceutic...-0.14-1.85%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$46.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Thomas J. Schall
CFO, Secretary &
Head-Investor Relations
Susan M. Kanaya
Corporate headquarters
Mountain View, California

Forecasts

Partner Offers